Compassionate UseInvestigational Access, Emergency Treatment Access
A regulatory pathway letting patients with a serious condition access an investigational treatment outside a trial when no comparable alternative exists.
Terms for how medicine prices are set and negotiated and how patients gain access to new treatments.
A regulatory pathway letting patients with a serious condition access an investigational treatment outside a trial when no comparable alternative exists.
A coverage arrangement in which a payer reimburses a treatment provisionally, subject to collecting further evidence confirming its value within a set timeframe.
A price reduction negotiated privately between a manufacturer and payer, keeping a higher public list price while offering a lower net price.